CTRP Terminology
CTRP Agent Terminology
Estrogen Receptor Family
NCI Drug Dictionary Terminology
Radioconjugate
F-18 16 Alpha-Fluoroestradiol
16 alpha-fluroestradiol-17 beta
500062
500062
500062
94153-53-4
A radiolabeled substance being studied as an imaging agent in breast cancer. F-18 16 alpha-fluoroestradiol binds to estrogen receptors and gives off radiation that can be detected by a PET scan. The PET scan forms an image that shows where cancer cells with estrogen receptors can be found in the body. It is a type of radioimaging agent.
A radiopharmaceutical consisting of an estradiol analogue radiolabeled with the positron-emitting isotope fluorine F 18. F-18 16 alpha-fluoroestradiol is actively taken up in tumor cells expressing the estrogen receptor (ER), allowing visualization of ER-positive tumor cells with positron emission tomography (PET). Uptake of this agent depends upon the ER status of target tissues.
C1831937
C62541
CTRP
F-18 16 Alpha-Fluoroestradiol
F-18 16 Alpha-Fluoroestradiol
F-18 16 Alpha-Fluoroestradiol
F-18 16 alpha-fluoroestradiol
F-18 FES
F-18_16_Alpha-Fluoroestradiol
FDA
FES
FLUOROESTRADIOL F-18
Fluorine-18 16 alpha-fluoroestradiol
Fluoroestradiol F-18
Indicator, Reagent, or Diagnostic Aid
Pharmacologic Substance
T32277KB09
FDA Established Names and Unique Ingredient Identifier Codes Terminology